National Institutes of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the ...

RTX is a non-addictive pain therapy derived from a cactus-like plant.

National Institute of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the plant ...

NIH Scientists Pioneer Promising Treatment for Intractable Cancer Pain - RTX is a Non-Addictive Pain Therapy Derived from a ...

FDA approves ALC's TRYPTYR, a new dry eye treatment with rapid tear production. The approval is supported by strong Phase 3 ...

When I was growing up in South Dakota, my mother of five, active children, me being the oldest, would suffer terribly from ...

INDICATIONS AND USAGE TRYPTYR (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Retinal vascular change or degeneration already has been associated with Alzheimer and Parkinson disease, and the findings ...

Dystrophin's isoforms are thought to contribute variably to neuropsychiatric disorders, behavioral disorders, and ...

The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for nerve dysfunction in your limbs,” says Eva Feldman, a professor of neurology at ...